BIDMC News and Notes
10/27/2009 (12:08:24pm)Tags: NIH transplant carbon monoxideComments: (0)
Leo Otterbein, PhD, a scientist in the Division of Transplantation at BIDMC whose novel research has revealed medical applications for carbon monoxide gas, has been awarded a $1.4 million, four-year EUREKA grant from the National Institutes of Health (NIH).
The award will enable Otterbein to continue to study the underlying biology behind this seemingly paradoxical idea and, if successful, could lead to new therapies for a range of medical applications from adjunct cancer treatments to fighting bacterial infections to helping kidney-transplant patients avoid organ rejection.
An acronym for Exceptional, Unconventional Research Enabling Knowledge Acceleration, EUREKA grants are part of an initiative unveiled last year by the NIH to fund innovative research and test new, unconventional ideas.
To learn more about Otterbein's work, click here.
Add a comment
Name:
Website:
Comment:
